3056
W. Itano et al.
LETTER
H), 7.48–7.44 (m, 2 H), 4.49–4.48 (br s, 1 H), 4.81–4.79 (br
s, 1 H), 4.56 (d, J = 7.3 Hz, 1 H), 4.34 (dd, J = 11.0, 5.8 Hz,
1 H), 4.28 (dd, J = 11.0, 6.7 Hz, 1 H), 4.20–4.16 (m, 1 H),
3.01–2.95 (m, 1 H), 2.87 (dd, J = 15.5, 8.3 Hz, 1 H), 2.50–
2.34 (m, 3 H), 2.21–2.16 (m, 2 H), 1.55–1.40 (m, 2 H), 1.06
(s, 3 H). 13C NMR (126 MHz, CDCl3): d = 167.83, 166.47,
153.63, 133.21, 129.85, 129.56 (2 C), 128.48 (2 C), 106.72,
90.49, 68.14, 61.78, 61.76, 57.96, 49.98, 45.69, 35.30,
28.92, 25.00, 19.67. FT-IR (neat): 2951, 1718, 1451, 1273,
1117, 713 cm–1. LRMS (ESI, MeOH): m/z = 360.1 [M +
Na+], 697.2 [2 M + Na+]. HRMS-FAB: m/z calcd for
C21H23NO3 [M + H+]: 338.1751; found: 338.1760.
(13) For supposed mechanism of a reductive N–O bond cleavage
with Mo, see: (a) Nitta, M.; Kobayashi, T. J. Chem. Soc.,
Perkin Trans. 1 1984, 2103. (b) Nitta, M.; Yi, A.;
Kobayashi, T. Bull. Chem. Soc. Jpn. 1985, 58, 991.
(c) Cicchi, S.; Goti, A.; Brandi, A.; Guarna, A.; Sarlo, F. D.
Tetrahedron Lett. 1990, 31, 3351.
(14) Analytical Data for 21.
Rf = 0.38 (silica gel, EtOAc–hexane, 1:2). FT-IR (neat):
2958, 2930, 2860, 1719, 1439, 1236, 1076, 831 cm–1. 1H
NMR (500 MHz, CDCl3): d = 7.12 (s, 1 H), 5.03–5.01 (m, 1
H), 5.00–4.98 (m, 1 H), 4.61 (d, J = 7.7 Hz, 1 H), 4.23 (dd,
J = 7.7, 6.8 Hz, 1 H), 3.82 (s, 3 H), 3.17 (dd, J = 6.8, 6.1 Hz,
1 H), 2.47–2.41 (m, 2 H), 2.17 (br d, J = 6.1 Hz, 1 H), 1.61–
1.47 (m, 2 H), 1.03 (s, 3 H). 13C NMR (126 MHZ, CDCl3):
d = 169.72, 164.32, 153.56, 153.08, 128.01, 109.12, 90.47,
66.92, 59.97, 55.75, 52.12, 51.79, 37.51, 31.00, 21.20.
LRMS (ESI, MeOH): m/z = 281.9 [M + Na+]. HRMS-FAB:
m/z calcd for C15H17CsNO3 [M + Cs+]: 392.0257; found:
392.0258. [a]D20 +36.4 (c 0.22, CHCl3).
(8) Stockley, M.; Clegg, W.; Fontana, G.; Golding, B. T.;
Martin, N.; Rigoreau, L. J. M.; Smith, G. C. M.; Griffin, R.
J. Bioorg. Med. Chem. Lett. 2001, 11, 2837.
(9) General Procedure for the Asymmetric Heck Reaction–
Carbanion Capture Process.
[Pd(allyl)Cl]2 (1.99 mg, 5.5 mmol, 2.5 mol%) and (S)-
BINAP (8.55 mg, 13.7 mmol, 6.3 mol%) were added to a
solution of 7 (61.5 mg, 0.218 mmol) in DMSO (1.0 mL,
0.218 M). After degassing, the sodium enolate of 15 (0.33
M, in DMSO, 1.32 mL, 0.436 mmol, 2 equiv) was gradually
added to the mixture. The reaction mixture was stirred at r.t.
for 1 h, diluted with Et2O, washed with 1 N aq HCl and brine,
dried (Na2SO4), and concentrated. The residue was purified
twice by silica gel column chromatography (Et2O–hexane,
1:25) to give 14 (68.5 mg, 82%, 83% ee) as colorless oil
(1:1 mixture of diastereomers). Rf = 0.39 (silica gel, EtOAc–
hexane, 1:3). FT-IR (neat): 2919, 2849, 1722, 1314, 1249,
1035, 821, 760 cm–1. 1H NMR (500 MHz, CDCl3): d = 7.28–
7.24 (m, 2 H), 6.90–6.88 (m, 2 H), 5.54 (dd, J = 5.5, 2.2 Hz,
0.5 H), 5.52–5.48 (m, 1 H), 5.54 (dd, J = 5.5, 2.5 Hz, 0.5 H),
4.91–4.82 (m, 2 H), 4.53–4.49 (m, 2 H), 4.16 (d, J = 17.4 Hz,
0.5 H), 4.14 (d, J = 17.4 Hz, 0.5 H), 4.11 (d, J = 17.4 Hz, 0.5
H), 4.08 (d, J = 17.4 Hz, 0.5 H), 3.81 (s, 3 H), 3.70, 3.66 (s,
1.5 H), 3.63 (d, J = 9.5 Hz, 0.5 H), 3.55 (d, J = 10.4 Hz, 0.5
H), 3.28–3.23 (m, 1 H), 2.38–2.36 (br s, 0.5 H), 2.29–2.17
(m, 2.5 H), 1.72–1.64 (m, 1 H), 1.51–1.41 (m, 1 H), 1.19,
1.15 (s, 1.5 H). 13C NMR (126 MHz, CDCl3): d = 168.64,
168.57, 159.46, 157.52, 157.40, 141.47, 141.14, 129.60 (2
C), 129.24, 128.92, 128.89, 113.82 (2 C), 106.07, 106.04,
74.58, 74.53, 73.00, 72.97, 61.17, 60.73, 57.22, 57.19,
56.51, 56.34, 55.25, 54.63, 54.17, 52.34, 52.20, 38.35,
38.32, 33.19, 27.68, 27.59. LRMS (ESI, MeOH): m/z =
407.1 [M + Na+], 791.2 [2 M + Na+]. HRMS-FAB: m/z calcd
for C23H28CsO5 [M + Cs+]: 517.0986; found: 517.0981. The
allylated product of 14 (Figure 3, 2.5 mg, 3%) was obtained
as the by-product.
(15) (a) Analytical Data for 12.
Rf = 0.28 (silica gel, EtOAc–hexane, 2 × 1:2). FT-IR (neat)
3438, 2953, 2925, 1710, 1437, 1222, 1082, 887 cm–1. 1H
NMR (500 MHz, CDCl3): d = 6.56 (d, J = 2.1 Hz, 1 H),
5.22–5.20 (m, 1 H), 5.03–5.01 (m, 1 H), 3.91–3.89 (m, 1 H),
3.88 (s, 3 H), 3.46 (ddd, J = 6.7, 4.9, 2.1 Hz, 1 H), 3.08 (dd,
J = 6.7, 6.7 Hz, 1 H), 2.61–2.54 (m, 1 H), 2.51–2.43 (m, 2
H), 2.16–2.13 (br s, 1 H), 1.97 (ddd, J = 13.2, 9.3, 9.3 Hz, 1
H), 1.51–1.46 (m, 1 H), 1.03 (s, 3 H). 13C NMR (126 MHz,
CDCl3): d = 209.04, 165.90, 164.46, 155.08, 136.02, 108.31,
81.70, 59.92, 59.01, 57.17, 52.47, 51.12, 31.85, 31.28,
24.25. LRMS (ESI, MeOH): m/z 285.0 [M + Na+]. HRMS-
FAB: m/z calcd for C15H18CsO4 [M + Cs+]: 395.0254; found:
395.0251. [a]D20 +62.5 (c 0.20, CHCl3). (b) The stereo-
chemistry at C5 was confirmed by NOE analysis after
protection of the hydroxyl group with a TBS group
(Scheme 8).
CO2Me
H
H
TBSCl
imidazole
12
6
DMF
5
O
Me
H
H
NOE 1.5%
NOE 3%
OTBS
Scheme 8
(16) Improvement of the C5–OH isomer ratio is still under
investigation.
(17) The DFT calculation was performed on Gaussian03 with
B3LYP/6-31+G(d).
(18) (a) Analytical Data for 25.
MeO2C
O
Rf = 0.33 (silica gel, EtOAc–hexane, 2 × 1:2). FT-IR (neat):
3406, 2924, 2852, 1710, 1438, 1221, 1086, 802 cm–1. 1H
NMR (500 MHz, CDCl3): d = 6.49 (d, J = 2.2 Hz, 1 H), 3.83
(s, 3 H), 3.77 (dd, J = 7.6, 4.6 Hz, 1 H), 3.39 (ddd, J = 7.0,
4.2, 2.2 Hz, 1 H), 2.99 (dd, J = 7.6, 7.0 Hz, 1 H), 2.16–2.10
(m, 1 H), 2.13 (d, J = 4.6 Hz, 1 H), 1.95–1.89 (m, 1 H), 1.61
(d, J = 4.2 Hz, 1 H), 1.51–1.41 (m, 2 H), 1.20 (s, 3 H), 1.03–
0.98 (m, 1 H), 0.64–0.60 (m, 1 H), 0.56–0.52 (m, 1 H), 0.46–
0.42 (m, 1 H). 13C NMR (126 MHz, CDCl3): d = 209.11,
165.87, 164.45, 135.61, 81.70, 59.80, 59.67, 58.79, 52.40,
49.19, 35.06, 31.57, 29.69, 26.35, 15.59, 7.15. LRMS (ESI,
MeOH): m/z = 298.8 [M + Na+]. HRMS-FAB: m/z calcd for
H
H
OPMB
Me
Figure 3
(10) Ohshima, T.; Sodeoka, M.; Shibasaki, M. Tetrahedron Lett.
1993, 34, 8509.
(11) Hassener, A.; Rai, K. M. L. Synthesis 1989, 57.
(12) Baraldi, P. G.; Barco, A.; Benetti, S.; Manfredini, S.;
Simoni, D. Synthesis 1987, 276.
C16H20CsO4 [M + Cs+] 409.0410; found: 409.0399. [a]D
+35.8 (c 0.12, CHCl3).
24
Synlett 2006, No. 18, 3053–3056 © Thieme Stuttgart · New York